Cognitive Stimulation in Elderly Individuals at Risk to Develop Dementia (Allena-Mente).

NCT01793493 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2023-09-13

No results posted yet for this study

Summary

The Allena-Mente study is a randomized, controlled, single-blind trial assessing the efficacy of cognitive stimulation (CS) compared to an active control group, participating to sanitary education lessons (AC). This non-pharmacological intervention is delivered to Mild Cognitive Impairment (MCI) and cognitively healthy individuals with first-degree relative with dementia (NDFAM).

Conditions

Interventions

OTHER

Cognitive stimulation

Participants are pooled in small groups (6-8 individuals). Each group participates to ten twice weekly meetings. Each CS session is run by one trained operator. One observer participates to the sessions to guarantee homogeneity between different operators. Exercises are structured with an increasing cognitive complexity and are tailored to the characteristics of the group. Meetings (each lasting about 2 hours) have a common structure: * body awakening (10 minutes) * cognitive stimulation (1 hour and a half) scheduled as follow: * temporospatial orientation * attentional abilities * one of the following cognitive areas: language, executive functions, verbal and visual memory (encoding, consolidation, retrieval)

OTHER

Sanitary education

Participants attend two weekly meetings (for a total of 3 hours) focused on lifestyle education and brain functioning.

Sponsors & Collaborators

  • Alzheimer Federation Italy

    collaborator OTHER
  • Camillo Golgi Geriatric Institute

    collaborator OTHER
  • University of Pavia

    collaborator OTHER
  • Mario Negri Institute for Pharmacological Research

    collaborator OTHER
  • Fondazione Golgi Cenci

    lead OTHER

Principal Investigators

  • Antonio Guaita, MD · GolgiCenci Foundation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2015-03-31
Completion
2015-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01793493 on ClinicalTrials.gov